SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-014486
Filing Date
2022-09-20
Accepted
2022-09-20 08:14:26
Documents
20
Period of Report
2022-09-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220919x8k.htm   iXBRL 8-K 48456
2 EX-1.1 tmb-20220919xex1d1.htm EX-1.1 621895
3 EX-5.1 tmb-20220919xex5d1.htm EX-5.1 15789
4 EX-99.1 tmb-20220919xex99d1.htm EX-99.1 12054
5 EX-99.2 tmb-20220919xex99d2.htm EX-99.2 11701
6 GRAPHIC tmb-20220919xex99d1001.jpg GRAPHIC 11583
7 GRAPHIC tmb-20220919xex99d2001.jpg GRAPHIC 11583
8 GRAPHIC tmb-20220919xex5d1001.jpg GRAPHIC 4128
9 GRAPHIC tmb-20220919xex5d1002.jpg GRAPHIC 5437
  Complete submission text file 0001558370-22-014486.txt   997231

Data Files

Seq Description Document Type Size
10 EX-101.SCH tmb-20220919.xsd EX-101.SCH 3025
11 EX-101.LAB tmb-20220919_lab.xml EX-101.LAB 15920
12 EX-101.PRE tmb-20220919_pre.xml EX-101.PRE 10046
14 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220919x8k_htm.xml XML 4848
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 221252109
SIC: 2834 Pharmaceutical Preparations